• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

COVID-19: Business update on Novartis operations

Article

Patrick Mooney, vice president and head of Ophthalmology Franchise (US) at Novartis, offers an update on how the company is responding to the impact of the global coronavirus epidemic and the internal changes that have been implemented to ensure the safety and health of its employees.

 

 

See more coronavirus coverage

Related Videos
© 2024 MJH Life Sciences

All rights reserved.